172 related articles for article (PubMed ID: 18566839)
1. Efficacy of intravenous pulse cyclophosphamide treatment versus combination of intravenous dexamethasone and oral cyclophosphamide treatment in steroid-resistant nephrotic syndrome.
Mantan M; Sriram CS; Hari P; Dinda A; Bagga A
Pediatr Nephrol; 2008 Sep; 23(9):1495-502. PubMed ID: 18566839
[TBL] [Abstract][Full Text] [Related]
2. Treatment of focal glomerulosclerosis with pulse steroids and oral cyclophosphamide.
Hari P; Bagga A; Jindal N; Srivastava RN
Pediatr Nephrol; 2001 Nov; 16(11):901-5. PubMed ID: 11685598
[TBL] [Abstract][Full Text] [Related]
3. Intravenous cyclophosphamide in steroid-resistant nephrotic syndrome.
Bajpai A; Bagga A; Hari P; Dinda A; Srivastava RN
Pediatr Nephrol; 2003 Apr; 18(4):351-6. PubMed ID: 12700961
[TBL] [Abstract][Full Text] [Related]
4. Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome.
Gulati A; Sinha A; Gupta A; Kanitkar M; Sreenivas V; Sharma J; Mantan M; Agarwal I; Dinda AK; Hari P; Bagga A
Kidney Int; 2012 Nov; 82(10):1130-5. PubMed ID: 22763815
[TBL] [Abstract][Full Text] [Related]
5. The clinical effectiveness and cost-effectiveness of treatments for children with idiopathic steroid-resistant nephrotic syndrome: a systematic review.
Colquitt JL; Kirby J; Green C; Cooper K; Trompeter RS
Health Technol Assess; 2007; 11(21):iii-iv, ix-xi, 1-93. PubMed ID: 17537341
[TBL] [Abstract][Full Text] [Related]
6. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
Li X; Li H; Ye H; Li Q; He X; Zhang X; Chen Y; Han F; He Q; Wang H; Chen J
Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
[TBL] [Abstract][Full Text] [Related]
7. Cyclosporin A is superior to cyclophosphamide in children with steroid-resistant nephrotic syndrome-a randomized controlled multicentre trial by the Arbeitsgemeinschaft für Pädiatrische Nephrologie.
Plank C; Kalb V; Hinkes B; Hildebrandt F; Gefeller O; Rascher W;
Pediatr Nephrol; 2008 Sep; 23(9):1483-93. PubMed ID: 18481113
[TBL] [Abstract][Full Text] [Related]
8. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
Hodson EM; Wong SC; Willis NS; Craig JC
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD003594. PubMed ID: 27726125
[TBL] [Abstract][Full Text] [Related]
9. Short term efficacy of intravenous dexamethasone and methylprednisolone therapy in steroid resistant nephrotic syndrome.
Hari P; Bagga A; Mantan M
Indian Pediatr; 2004 Oct; 41(10):993-1000. PubMed ID: 15523124
[TBL] [Abstract][Full Text] [Related]
10. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
Liu ID; Willis NS; Craig JC; Hodson EM
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31749142
[TBL] [Abstract][Full Text] [Related]
11. Intravenous pulse cyclophosphamide--is it effective in children with steroid-resistant nephrotic syndrome?
Alshaya HO; Al-Maghrabi JA; Kari JA
Pediatr Nephrol; 2003 Nov; 18(11):1143-6. PubMed ID: 13680329
[TBL] [Abstract][Full Text] [Related]
12. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated.
Ehrich JH; Geerlings C; Zivicnjak M; Franke D; Geerlings H; Gellermann J
Nephrol Dial Transplant; 2007 Aug; 22(8):2183-93. PubMed ID: 17504846
[TBL] [Abstract][Full Text] [Related]
13. Intravenous methylprednisolone in idiopathic childhood nephrotic syndrome.
Shenoy M; Plant ND; Lewis MA; Bradbury MG; Lennon R; Webb NJ
Pediatr Nephrol; 2010 May; 25(5):899-903. PubMed ID: 20108003
[TBL] [Abstract][Full Text] [Related]
14. Steroid-resistant nephrotic syndrome: the influence of race on cyclophosphamide sensitivity.
Bhimma R; Adhikari M; Asharam K
Pediatr Nephrol; 2006 Dec; 21(12):1847-53. PubMed ID: 16967286
[TBL] [Abstract][Full Text] [Related]
15. Intravenous pulse cyclophosphamide--a new regime for steroid-resistant minimal change nephrotic syndrome.
Elhence R; Gulati S; Kher V; Gupta A; Sharma RK
Pediatr Nephrol; 1994 Feb; 8(1):1-3. PubMed ID: 8142205
[TBL] [Abstract][Full Text] [Related]
16. Steroid-resistant nephrotic syndrome: long-term evolution after sequential therapy.
Peña A; Bravo J; Melgosa M; Fernandez C; Meseguer C; Espinosa L; Alonso A; Picazo ML; Navarro M
Pediatr Nephrol; 2007 Nov; 22(11):1875-80. PubMed ID: 17876609
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
Choudhry S; Bagga A; Hari P; Sharma S; Kalaivani M; Dinda A
Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
[TBL] [Abstract][Full Text] [Related]
18. Steroid resistant nephrotic syndrome is sustained remission attainable.
Nammalwar BR; Vijaykumar M; Prahlad N; Jain DV
Indian Pediatr; 2006 Jan; 43(1):39-43. PubMed ID: 16465005
[TBL] [Abstract][Full Text] [Related]
19. Intravenous cyclophosphamide is the drug of choice for steroid dependent nephrotic syndrome.
Bircan Z; Kara B
Pediatr Int; 2003 Feb; 45(1):65-7. PubMed ID: 12654072
[TBL] [Abstract][Full Text] [Related]
20. Late resistance to corticosteroids in nephrotic syndrome.
Srivastava RN; Agarwal RK; Moudgil A; Bhuyan UN
J Pediatr; 1986 Jan; 108(1):66-70. PubMed ID: 3944696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
